Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
The kinase inhibitors sunitinib and sorafenib differentially affect NK cell antitumor reactivity in vitroMatthias Krusch, Julia Salih, Manuela Schlicke, et al.
European Journal of Haematology|April 21, 2016
Expression of RANK-L and in part of PD-1 on blasts in patients with acute myeloid leukemia correlates with prognosisJoerg Uwe Schmohl, Tina Nuebling, Julia Wild, et al.
Experimental Hematology|June 27, 2006
The role of leukemia-derived B7-H1 (PD-L1) in tumor-T-cell interactions in humansHelmut Rainer Salih, Sabine Wintterle, Matthias Krusch, et al.
Blood|April 26, 2003
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemiaHelmut Rainer Salih, Holger Antropius, Friederike Gieseke, et al.
Cancer Research|December 1, 2011
Platelet-derived MHC class I confers a pseudonormal phenotype to cancer cells that subverts the antitumor reactivity of natural killer immune cellsTheresa Placke, Melanie Örgel, Martin Schaller, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
Generation and preclinical characterization of a Fc-optimized GITR-Ig fusion protein for induction of NK cell reactivity against leukemiaBenjamin Joachim Schmiedel, Antje Werner, Julia Steinbacher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 26, 2012
Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responsesJulia Hilpert, Ludger Grosse-Hovest, Frank Grünebach, et al.
BMC Cancer|January 18, 2016
Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patternsKerstin Maria Kampa-Schittenhelm, Olaf Salitzky, Figen Akmut, et al.
Anticancer Research|July 26, 2007
Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolismStefan Holdenrieder, Peter Eichhorn, Ulrich Beuers, et al.
Neoplasia (New York, N.Y.)|October 10, 2018
Expression of the Immune Checkpoint Modulator OX40 in Acute Lymphoblastic Leukemia Is Associated with BCR-ABL PositivityKathrin Rothfelder, Ilona Hagelstein, Malte Roerden, et al.
Pageof 4